HEALTHCARE

  Market Analysis: The global malaria diagnostics market is predicted to grow at a 4.6% CAGR over the forecast period (2018-2023), states the latest Market Research Future (MRFR) report. Malaria is a life-threating disease resulting from a parasite that is transmitted from the bite of infected anopheles’ mosquitoes. These infected mosquitoes transport the parasite. The moment such infected mosquitoes bite a person, the parasite gets released into their bloodstream. As the body becomes the host of these parasites, this passes to the liver and then matures. The mature parasites after a couple of days enter the bloodstream and begin infecting the red blood cells. People suffering from malaria experience weakness, headache, fever, and vomiting. Malaria diagnostics is made through the microscopic test of the blood samples. Fever and other signs similar to malaria demand careful evaluation for diagnosing malaria. This diagnosis includes identifying antigens/products or malaria...

Market Highlights: Primary and precise diagnosis of malaria is essential for both fast and effective disease management and observation. Superior quality malaria diagnosis systems are important in all settings as misdiagnosis or misinterpretation can result in substantial morbidity and mortality. World Health Organization (WHO) recommends a quick malaria diagnosis either by microscopy or malaria rapid diagnostic test (RDT) in all patients with suspected malaria before treatment is being administered. Diagnostic testing improves the overall management of patients with febrile illnesses and may also help to decrease the emergence and spread of drug resistance by storing antimalarials for those who have the disease. The scope of malaria diagnostics is growing rapidly with technological advancements and a growing number of investments. Also, growth in a number of hospitals and healthcare facilities, and initiatives taken by the government are the major factors driving the growth of the...